IHT Wealth Management LLC Purchases 60,850 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

IHT Wealth Management LLC raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 90.8% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 127,873 shares of the exchange traded fund’s stock after acquiring an additional 60,850 shares during the period. IHT Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $12,590,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Tidemark LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after acquiring an additional 199 shares during the period. ORG Partners LLC bought a new position in SPDR S&P Biotech ETF in the 2nd quarter worth about $40,000. Quintet Private Bank Europe S.A. purchased a new position in SPDR S&P Biotech ETF during the 3rd quarter valued at about $40,000. ORG Wealth Partners LLC bought a new stake in shares of SPDR S&P Biotech ETF during the third quarter valued at about $44,000. Finally, Howe & Rusling Inc. purchased a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth about $49,000.

SPDR S&P Biotech ETF Stock Down 1.0 %

NYSEARCA:XBI traded down $1.03 during mid-day trading on Tuesday, hitting $98.28. 1,234,252 shares of the stock traded hands, compared to its average volume of 9,467,126. The business’s 50-day moving average price is $98.22 and its 200 day moving average price is $96.64. The company has a market cap of $7.49 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12-month low of $77.21 and a 12-month high of $105.47.

SPDR S&P Biotech ETF Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Articles

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.